NCT01528592View on ClinicalTrials.gov

PharmacoMRI of Parkinson Disease

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Parkinson's Disease
Interventions
DRUG

Carbidopa-Levodopa

Equivalent amount of carbidopa-levodopa will be provide to you

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01528592 - PharmacoMRI of Parkinson Disease | Biotech Hunter | Biotech Hunter